Literature DB >> 30006716

Transection and Crush Models of Nerve Injury to Measure Repair and Remyelination in Peripheral Nerve.

Xin-Peng Dun1, David B Parkinson2.   

Abstract

Injury to the peripheral nervous system begins a well-characterized process within both neurons and Schwann cells to allow axonal regrowth, remyelination, and functional repair. Models of peripheral nerve injury have been widely used to study the behavior of Schwann cells, neurons, and other cell types such as macrophages as the events of Wallerian degeneration and regeneration take place. The most commonly used approaches in rodent models to model nerve injury in human patients are sciatic nerve transection and nerve crush, and both have well established time courses of demyelination, immune cell influx, axonal regrowth, and remyelination. We describe the techniques of sciatic nerve surgery for transection and crush injury, together with methods for the analysis of events within peripheral nerve repair in these two models.

Entities:  

Keywords:  Demyelination; Nerve crush; Nerve transection; Peripheral nerve; Remyelination; Schwann cell; Sciatic; Surgery

Mesh:

Year:  2018        PMID: 30006716     DOI: 10.1007/978-1-4939-7862-5_20

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  Analysis of Schwann Cell Migration and Axon Regeneration Following Nerve Injury in the Sciatic Nerve Bridge.

Authors:  Bing Chen; Quan Chen; David B Parkinson; Xin-Peng Dun
Journal:  Front Mol Neurosci       Date:  2019-12-10       Impact factor: 5.639

2.  Compound Motor Action Potentials During a Modest Nerve Crush.

Authors:  Mohammed Nazmy Hamad; Nickolas Boroda; Diego Barragan Echenique; Raymond A Dieter; Farid M L Amirouche; Mark H Gonzalez; James M Kerns
Journal:  Front Cell Neurosci       Date:  2022-03-30       Impact factor: 5.505

3.  Dynamic expression of Slit1-3 and Robo1-2 in the mouse peripheral nervous system after injury.

Authors:  Bing Chen; Lauren Carr; Xin-Peng Dun
Journal:  Neural Regen Res       Date:  2020-05       Impact factor: 5.135

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.